The emerging approach of tirzepatide peptide represents a exciting breakthrough in the management of the condition. Distinct from existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and the GIP hormone – leading to enhanced glucose management and potential weight loss. Researchers a